{
    "nctId": "NCT00214032",
    "briefTitle": "Pycnogenol for the Treatment of Lymphedema",
    "officialTitle": "Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 2,
    "primaryOutcomeMeasure": "reduction of arm lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \\> 6 months from last surgical and/or radiation treatment to the affected axilla\n* Unilateral lymphedema of the upper extremity\n\nExclusion Criteria:\n\n* May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}